Release of Immunosuppressive Substances after Gastric Resection is More Prolonged than after Mastectomy in Humans

International Surgery

Volumn 83, Issue 3, 1998, Pages 210-214

  Shirakawa, T ^a   Tokunaga, A ^a   Onda, M ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer surgery; Gastric cancer surgery; Immunosuppression; Local exudate; Natural killer cell activity; Prostaglandin E2; Soluble interleukin 2 receptor; Transforming growth factor 1

Indexed keywords

CYTOKINE; INTERLEUKIN 2 RECEPTOR; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; ASCITES FLUID; BREAST TUMOR; CELLULAR IMMUNITY; CHEMISTRY; EXUDATE; FEMALE; GASTRECTOMY; HUMAN; IMMUNOLOGY; MALE; MASTECTOMY; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; STOMACH TUMOR; TIME;

ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; BREAST NEOPLASMS; CYTOKINES; DINOPROSTONE; EXUDATES AND TRANSUDATES; FEMALE; GASTRECTOMY; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MALE; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; STOMACH NEOPLASMS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032106713     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lazarou SA, Barbul A, Wasserkrug HL, Efron G. The wound is a possible source of posttraumatic immunosuppression. Arch Surg 1989;124:1429-31.
2. Tokunaga A. Onda M, Fujita I, Okuda T, Mizutani T, Kiyama T et al. Sequential changes in the cell mediators of peritoneal and wound fluids after surgery. Jpn J Surg 1993;23:841-4.
3. Fujita I, Onda M, Tokunaga A. Expression of interleukin-6 and tumor necrosis factor in peritoneal mononuclear cells after gastrectomy. Wound Rep Reg 1995;3:168-75.
4. 2 critically depends on interleukin-2. Eur J Immunol 1995;25:59-63.
5. Brunda MJ, Herberman RB, Holden HT. Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 1980;6:2682-7.
6. 2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 1993;72:491-501.
7. 2. Scand J Immunol 1993;37:71-6.
8. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB et al. Effect of transforming growth factor β on the functions of natural killer cells: depressed cytologic activity and blunting of interferon responsiveness. J Immunol 1986;136:3916-20.
9. Gray JD, Hirokawa M, Horwitz A. The role of transforming growth factor β in the generation of suppression: an interaction between CDS+ T and NK cells. J Exp Med 1994;180:1937-42.
10. Colacchio TA, Yeager MP, Hildebrandt LW. Perioperative immunomodulation in cancer surgery. Am J Surg 1994;167:174-9.
11. Little D, Regan M, Keane RM, Bouchier-Hayes D. Perioperative immune modulation. Surgery 1993;114:87-91.
12. Eggermont AMM, Steller EP, Sugarbaker PH. Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. Surgery 1987;102:71-8.
13. Uchida A, Kolb R, Micksche M. Generation of suppressor cells for natural killer activity in cancer patients after surgery. J Natl Cancer Inst 1982;68:735-41.
14. Su HC, Ishikawa R, Biron A. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J Immunol 1993;151:4874-90.
15. Hanna N. The role of natural killer cells in the control of tumor growth and metastasis. Biochim Biophys Acta 1985;780:213-26.
16. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991;45:319-26.
17. Murakami S, Satomi A, Ishida K, Murai H, Matsuki M, Hashimoto T. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer. Cancer 1994;74:2745-8.
18. Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA et al. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer. Cancer 1995;76:1615-20.
19. Stasi R, Zinzani PL, Galieni P, Lauta VM, Damasio E, Dispensa E et al. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Cancer 1994;74:1792-800.
20. 2-mediated suppression of cellular immunity in colon cancer patients. Surgery 1984;95:71-7.
21. 2) in severely burned patients. Burns 1996;22:298-302.
22. Cromack DT, Sporn MB, Roberts AB, Merino MJ, Dart LL, Norton JA. Transforming growth factor-β levels in rat wound chambers. J Surg Res 1987;42:622-8.
23. Meert KL, Ofenstein JP, Genyea C, Sarnaik AP, Kaplan J. Elevated transforming growth factor-β concentration correlates with posttrauma immunosuppression. J Trauma 1996;40:901-6.
24. Gaillard RC. Neuroendocrine-immune system interactions: the immune-hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 1994;5:303-9.